Statins and Risk of Myocardial Infarction in Real Life in France
Completed
- Conditions
- Myocardial Infarction
- Registration Number
- NCT00679575
- Lead Sponsor
- AstraZeneca
- Brief Summary
The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 13171
Inclusion Criteria
- Patients can speak French or English
- Patients can be interviewed by telephone
- Place of usual residence in the area of recruitment
Read More
Exclusion Criteria
- Patients refusing to participate in the study
- Patients who cannot be reached by telephone
- Previous history of myocardial infarction
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France in 2011
- Secondary Outcome Measures
Name Time Method Assess the interaction between statin treatment and risk factors such as cholesterol, age, gender, tobacco, alcohol, co-prescriptions, co-morbidities in 2011 Assess the populational impact of statins usage on the risk of having a first myocardial infarction in 2011 Assess the risk of having a first myocardial infarction according to high and low dosages of statins in 2011
Trial Locations
- Locations (1)
Research Site
🇫🇷Villefranche de Rouergue, France